The quadrivalent recombinant influenza vaccine (RIV4) demonstrated non-inferior immune responses in children and adolescents aged 9-17 years compared with adults aged 18-49 years, with the safety ...

An international team of researchers co-led by Job Dekker, PhD, at UMass Chan Medical School, have identified rules that tell cells how to fold DNA into the tightly packed, iconic X-shaped chromosomes ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...

According to Nova One Advisor, the global recombinant proteins market size was estimated at USD 3.25 billion in 2024 and is expected to hit around USD 8.66 billion by 2034, poised to grow at a CAGR of ...

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

Figure 1: The functionality of recombinant proteins aggregated as inclusion bodies. This evidence of biological activity in inclusion bodies indicates that aggregation of recombinant proteins in ...

Sydney-based biotech company All G affirmed the GRAS status of its recombinant bovine lactoferrin, as the company tees up the availability of a human equivalent of the highly sought-after food and ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...

The thought of your chromosomes breaking may send shivers down your spine. But for developing egg or sperm cells, it’s essential. In her laboratory, Lexy von Diezmann, a new College of Biological ...